Ethiopia & Moderna

Ethiopia: Ethiopia>>> is one of ten African countries identified by the United States — Centers for Disease Control and Prevention>>> as being at risk of Ebola infection due to the regional spread.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

Ethiopia: Ethiopia>>> is mentioned as one of the Ebola-affected countries from which travelers arrived in District.

Moderna: Moderna is one of the groups receiving funding to develop an Ebola vaccine, indicating potential future market opportunities.

Ethiopia: Ethiopia>>> is one of ten African countries identified by the United States — Centers for Disease Control and Prevention>>> as being at elevated risk of Ebola transmission due to cross-border population movement.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.

Ethiopia: Ethiopia is hosting the headquarters of the African counterpart to the European Union — European Centre for Disease Prevention and Control, where an expert is being deployed.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.